HER2+ early breast cancers where shorter-course trastuzumab could be an option

Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with […]
» Read morenohealthproblemsnews.com
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac toxicity with […]
» Read moreAdjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free […]
» Read moreYoung cancer patients at the crossroads of childhood and adulthood seem to be stuck in a treatment impasse. A study […]
» Read moreRecent advances in kidney research have yielded dramatic headlines touting scientists’ ability to grow kidneys in the lab. But some […]
» Read moreType 2 diabetes is a common condition. A 2017 report from the Centers for Disease Control and Prevention (CDC) found […]
» Read moreA research team at the University of Turku in Finland discovered a link between the interplay of certain simultaneously occurring […]
» Read moreIn atherosclerosis, plaque builds up inside the arteries, making them less elastic and narrowing them down over time. This limits […]
» Read moreAssisted ventilation is crucial to support very preterm babies, however the treatment often leads to chronic lung disease. While the […]
» Read moreTHURSDAY, Aug. 16, 2018 — A blood test seems to detect signs of gestational diabetes as early as the 10th […]
» Read moreAmong individuals with head and neck cancer (HNC), those who experienced childhood trauma were more likely to have advanced cancer, […]
» Read more